Free Trial

Emmett Investment Management LP Cuts Holdings in National Health Investors, Inc. $NHI

National Health Investors logo with Finance background

Key Points

  • Emmett Investment Management LP reduced its holdings in National Health Investors by 38.3%, now owning 21,246 shares valued at approximately $1,578,000.
  • National Health Investors recently increased its quarterly dividend to $0.92, reflecting a 4.8% dividend yield, up from the previous $0.90 dividend.
  • The company's stock has a current market capitalization of $3.61 billion and reported a earnings per share (EPS) of $1.22, exceeding analysts' estimates.
  • Five stocks we like better than National Health Investors.

Emmett Investment Management LP reduced its position in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) by 38.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,246 shares of the real estate investment trust's stock after selling 13,200 shares during the quarter. National Health Investors accounts for approximately 1.4% of Emmett Investment Management LP's investment portfolio, making the stock its 21st biggest holding. Emmett Investment Management LP's holdings in National Health Investors were worth $1,578,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Raymond James Financial Inc. bought a new stake in shares of National Health Investors during the 4th quarter worth about $2,219,000. Barclays PLC lifted its holdings in National Health Investors by 7.6% during the 4th quarter. Barclays PLC now owns 77,122 shares of the real estate investment trust's stock worth $5,344,000 after purchasing an additional 5,419 shares during the last quarter. Mariner LLC grew its stake in shares of National Health Investors by 26.3% in the fourth quarter. Mariner LLC now owns 4,295 shares of the real estate investment trust's stock valued at $298,000 after acquiring an additional 894 shares in the last quarter. NewEdge Advisors LLC acquired a new stake in shares of National Health Investors in the fourth quarter valued at approximately $83,000. Finally, CANADA LIFE ASSURANCE Co raised its position in shares of National Health Investors by 9.5% in the fourth quarter. CANADA LIFE ASSURANCE Co now owns 67,322 shares of the real estate investment trust's stock valued at $4,665,000 after buying an additional 5,820 shares in the last quarter. 62.51% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Truist Financial boosted their price target on National Health Investors from $77.00 to $81.00 and gave the company a "buy" rating in a research note on Friday, August 15th. KeyCorp raised shares of National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 price target for the company in a report on Thursday, July 10th. Finally, Wedbush raised shares of National Health Investors to a "strong-buy" rating in a research note on Wednesday, July 2nd. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, National Health Investors currently has a consensus rating of "Buy" and a consensus target price of $85.40.

Check Out Our Latest Report on National Health Investors

National Health Investors Price Performance

NHI traded down $0.8190 on Monday, reaching $77.0510. The stock had a trading volume of 37,044 shares, compared to its average volume of 246,131. The company has a current ratio of 10.91, a quick ratio of 10.91 and a debt-to-equity ratio of 0.75. The company has a market capitalization of $3.66 billion, a price-to-earnings ratio of 24.63, a price-to-earnings-growth ratio of 3.34 and a beta of 0.73. National Health Investors, Inc. has a fifty-two week low of $65.13 and a fifty-two week high of $86.13. The firm has a 50-day moving average of $72.05 and a 200-day moving average of $72.57.

National Health Investors (NYSE:NHI - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 EPS for the quarter, beating analysts' consensus estimates of $1.16 by $0.06. National Health Investors had a return on equity of 10.32% and a net margin of 40.97%.The firm had revenue of $70.27 million for the quarter, compared to analyst estimates of $86.46 million. During the same quarter in the previous year, the company posted $1.18 EPS. The business's revenue was up 6.7% on a year-over-year basis. As a group, sell-side analysts anticipate that National Health Investors, Inc. will post 4.41 EPS for the current year.

National Health Investors Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be given a dividend of $0.92 per share. The ex-dividend date of this dividend is Tuesday, September 30th. This is a positive change from National Health Investors's previous quarterly dividend of $0.90. This represents a $3.68 annualized dividend and a dividend yield of 4.8%. National Health Investors's payout ratio is presently 117.57%.

National Health Investors Profile

(Free Report)

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Featured Articles

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Should You Invest $1,000 in National Health Investors Right Now?

Before you consider National Health Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.

While National Health Investors currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.